文献速递冠心病心力衰竭与心肌病

Takotsubo综合征:病理生理学、新概念与临床意义

Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications.
PubMed 文献 · Circulation · 2022-03-28

Takotsubo综合征表现为急性短暂性左心室收缩功能障碍,就诊时难以与急性心肌梗死区分。近期研究证实患者存在持续细微心脏功能障碍及高负担不良心血管事件,机制尚未阐明,缺乏循证干预。

要点

  • Takotsubo综合征急性期需与急性心肌梗死鉴别。
  • 左室射血分数恢复后仍可有持续症状和心功能障碍。
  • 主要不良心血管事件负担高,接近急性冠脉综合征患者。

核心结论

  • Takotsubo综合征并非良性自限性疾病,患者存在持续细微心脏功能障碍和高负担不良心血管事件。
  • 其病理生理机制尚未完全阐明,儿茶酚胺诱导的心肌损伤是最公认理论但无法解释所有临床特征。
  • 缺乏针对急性发作、复发预防和主要不良心血管事件预防的循证干预措施。

研究设计与样本

  • 综述文章,总结Takotsubo综合征的病理生理学、新概念和临床意义。

主要发现

  • 患者可有持续细微的进行性心脏功能障碍,许多人在左心室射血分数恢复后仍有受限症状。
  • 患者主要不良心血管事件发生率高,接近急性冠脉综合征患者。
  • 儿茶酚胺诱导的心肌损伤是最成熟理论,但 numerous 其他通路和异常正在涌现。

临床怎么用

  • 临床医生应认识到Takotsubo综合征患者左室射血分数恢复后仍可能存在持续症状和心功能障碍。
  • 需关注患者后续主要不良心血管事件风险,其负担接近急性冠脉综合征患者。
  • 目前缺乏循证干预,管理应基于对病理生理的进一步理解。

局限性

  • 对疾病潜在病理生理学理解不足,缺乏循证干预。
  • 需要进一步研究以开展针对因果通路的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Takotsubo syndrome is a condition characterized by acute transient left ventricular systolic dysfunction, which at presentation can be challenging to distinguish from acute myocardial infarction. Although previously thought to be a benign, self-limiting condition, recent studies have confirmed that patients with takotsubo syndrome have persistent subtle ongoing cardiac dysfunction, and many continue to have limiting symptoms despite restoration of left ventricular ejection fraction. Moreover, these patients have a substantial burden of morbidity and mortality, as well, with high rates of subsequent major adverse cardiovascular events that approach those of patients with acute coronary syndrome. The mechanisms behind this condition remain elusive. Despite substantial research, the medical community continues to have an incomplete understanding of its underlying pathogenesis and pathophysiology. Catecholamine-induced myocardial injury is the most established and well-known theory, but this does not explain all the clinical features and presentations of the condition, and numerous other pathways and abnormalities are emerging. Because of the poor understanding of its underlying pathophysiology, there is a lack of evidence-based interventions to treat the acute episode, to avoid recurrences, and to prevent major adverse cardiovascular events. This highlights the need for further research to gain a better understanding of the underlying pathophysiology to inform appropriate randomized controlled trials of interventions targeting the causative pathways. Only then can evidence-based management strategies be established to improve clinical outcomes of this potentially lethal condition.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Singh, Khan, Gamble, et al. Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications. Circulation. 2022. PMID: 35344411. doi:10.1161/CIRCULATIONAHA.121.055854

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。